Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods

被引:11
作者
Ednie, LM
Credito, KL
Khantipong, M
Jacobs, MR
Appelbaum, PC
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol Clin Microbiol, Hershey, PA 17033 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
D O I
10.1093/jac/45.5.633
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chequerboard titrations were used to test the activity of trovafloxacin, alone and in combination with clindamycin or metronidazole, against 156 Gram-positive or Gram-negative anaerobes, including 47 Bacteroides fragilis group, 36 Prevotella spp., 26 fusobacteria, 21 peptostreptococci and 26 clostridia. MIC50/MIC90 values (mg/L) of each drug alone against all 156 strains were: trovafloxacin, 0.5/1; clindamycin, 0.25/2; metronidazole, 1/2. Synergy (FIC indices less than or equal to 0.5) was seen in two strains with trovafloxacin plus clindamycin, and seven with trovafloxacin plus metronidazole. All other combinations were additive (FIC indices >0.5-2.0); no antagonism (FIC indices >4.0) was seen. In addition, synergy was tested by time-kill methodology for each of the above combinations against 12 Gram-positive or Gram-negative strains. Results indicated that synergy (defined as a greater than or equal to 2 log(10) decrease in cfu/mL at 48 h compared with the more active drug alone) was found between trovafloxacin at or below the MIC and both clindamycin and metronidazole at or below the MIC in one strain each of Bacteroides fragilis, Bacteroides thetaiotaomicron, Prevotella intermedia, Fusobacterium varium, Peptostreptococcus asaccharolyticus and Clostridium bifermentans. Synergy between trovafloxacin (less than or equal to MIC) and metronidazole alone was seen in one strain each of Bacteroides distasonis, Prevotella bivia, Fusobacterium mortiferum, P. asaccharolyticus and C. bifermentans. In many cases of synergy, including those at the trovafloxacin MIC, regrowth after 48 h, which was commonly seen with trovafloxacin alone, was inhibited, and 99.9% killing was observed with the combination after 48 h, but not with trovafloxacin alone.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 21 条
[1]   SUSCEPTIBILITY OF 539 GRAM-POSITIVE AND GRAM-NEGATIVE ANAEROBES TO NEW AGENTS, INCLUDING RP59500, BIAPENEM, TROSPECTOMYCIN AND PIPERACILLIN TAZOBACTAM [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (02) :223-231
[2]   Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies [J].
Bajaksouzian, S ;
Visalli, MA ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1073-1076
[3]   Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods [J].
Bajaksouzian, S ;
Visalli, MA ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :1973-1976
[4]   Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa [J].
Cappelletty, DM ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :677-683
[5]   THE IN-VITRO ACTIVITY OF CP-99,219, A NEW NAPHTHYRIDONE ANTIMICROBIAL AGENT - A COMPARISON WITH FLUOROQUINOLONE AGENTS [J].
CHILD, J ;
ANDREWS, J ;
BOSWELL, F ;
BRENWALD, N ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (06) :869-876
[6]  
Eliopolous GM., 1996, Antibiotics in laboratory medicine, P330
[7]   INVITRO ACTIVITY OF CP-99,219, A NEW FLUOROQUINOLONE, AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE BACTERIA [J].
ELIOPOULOS, GM ;
KLIMM, K ;
ELIOPOULOS, CT ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :366-370
[8]   Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group [J].
Falagas, ME ;
McDermott, L ;
Snydman, DR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2047-2049
[9]   In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli [J].
Fass, RJ ;
Barnishan, J ;
Solomon, MC ;
Ayers, LW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1412-1418
[10]   INVITRO ANTIMICROBIAL ACTIVITY OF CP-99,219, A NOVEL AZABICYCLO-NAPHTHYRIDONE [J].
GOODING, BB ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :349-353